Minnesota 2023-2024 Regular Session

Minnesota House Bill HF1711

Introduced
2/13/23  
Refer
2/13/23  

Caption

Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.

Impact

This legislation is expected to have significant implications for state laws governing pharmacy benefit managers and health insurance practices. By mandating the direct application of compensation to reduce costs for consumers, HF1711 seeks to enhance transparency in drug pricing and alleviate the financial burden on individuals who rely on prescription medications. The requirement for annual reporting from PBMs and health carriers to demonstrate compliance ensures ongoing accountability and oversight in the administration of prescription drug benefits.

Summary

House File 1711 (HF1711) is a legislative proposal aimed at ensuring that pharmacy benefit managers (PBMs) and health carriers are required to use any received compensation related to prescription drugs to benefit covered persons directly. The bill mandates that these entities remit all financial benefits received from drug manufacturers to the covered persons at the point of sale, thereby reducing their out-of-pocket costs for medications. The bill has an effective date of January 1, 2024, establishing clear responsibilities for managing prescription drug costs in the healthcare system.

Contention

Notable points of contention surrounding HF1711 include concerns over the operational impact on pharmacy benefit managers and health carriers, who may face challenges adapting their business models to comply with the new requirements. Proponents of the bill argue that it promotes consumer welfare and reduces unnecessary costs, while critics may voice concerns about potential increases in premiums or reduced provider options as a result of tighter regulations. The discussion points to a broader debate on how to balance the interests of consumers, healthcare providers, and pharmaceutical companies within the state’s regulatory framework.

Companion Bills

MN SF2889

Similar To Pharmacy benefit managers and health carriers requirement to use prescription drug rebates and other compensation to benefit covered persons

Previously Filed As

MN SF2889

Pharmacy benefit managers and health carriers requirement to use prescription drug rebates and other compensation to benefit covered persons

MN HF1075

Pharmacy benefit managers and health carriers required to use prescription drug rebates and other compensation to benefit covered persons, and report required.

MN SF1877

Pharmacy benefit managers and health carriers usage of prescription drug rebates and other compensation requirement to benefit covered persons provision

MN HF294

Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.

MN SF482

Requirements establishment for pharmacy benefit managers and health carriers related to clinician-administered drugs

MN HF544

Pharmacy benefit manager and health carrier requirements established related to clinician-administered drugs.

MN SF1876

Pharmacy benefit managers and health carriers inclusion of lower-cost drugs in formularies requirement provision and lowest out-of-pocket-cost drug to patient formulary tiering preference provision

MN SB01366

An Act Concerning Pharmacy Benefits Managers And Prescription Drug Rebate Reporting Requirements.

MN HF5469

Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to drug with lowest out-of-pocket cost to patient.

MN HF1076

Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to the drug with the lowest out-of-pocket cost to the patient.

Similar Bills

No similar bills found.